Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AVNI PATEL FINN

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1184987315
CMS profile
368764
Location
NASHVILLE, TN

General Payments · PY2019–2024

$40,548.22

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,660.76

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $9,290.00 5
Food and Beverage $351.48 8
Travel and Lodging $19.28 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genentech USA, Inc. $6,167.52 4
ABBVIE INC. $3,256.18 4
Bausch & Lomb Americas Inc. $99.90 2
Genentech, Inc. $89.68 2
Regeneron Pharmaceuticals, Inc. $23.98 1
Biogen, Inc. $23.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,200.30 10
PY2020 $3,181.61 3
PY2021 $3,632.57 6
PY2022 $6,870.20 18
PY2023 $13,002.78 14
PY2024 $9,660.76 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $36.90 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105191673 CMS
ABBVIE INC. $2,400.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1105191675 CMS
ABBVIE INC. $19.28 08/21/2024 Travel and Lodging Undisputed 01/23/2026 1105191677 CMS
ABBVIE INC. $800.00 09/16/2024 Consulting Fee Undisputed 01/23/2026 1105191679 CMS
Bausch & Lomb Americas Inc. $15.81 12/13/2024 Food and Beverage Undisputed 01/23/2026 1140307752 CMS
Bausch & Lomb Americas Inc. $84.09 12/18/2024 Food and Beverage Undisputed 01/23/2026 1140307754 CMS
Biogen, Inc. $23.50 04/21/2024 Food and Beverage Undisputed 01/23/2026 1104838465 CMS
Genentech USA, Inc. $77.52 03/04/2024 Food and Beverage Undisputed 01/23/2026 1132980065 CMS
Genentech USA, Inc. $840.00 04/11/2024 Consulting Fee Undisputed 01/23/2026 1132980067 CMS
Genentech USA, Inc. $2,520.00 06/20/2024 Consulting Fee Undisputed 01/23/2026 1132980069 CMS
Genentech USA, Inc. $2,730.00 08/17/2024 Consulting Fee Undisputed 01/23/2026 1132980075 CMS
Genentech, Inc. $22.73 10/30/2024 Food and Beverage Undisputed 01/23/2026 1132980071 CMS
Genentech, Inc. $66.95 11/10/2024 Food and Beverage Undisputed 01/23/2026 1132980073 CMS
Regeneron Pharmaceuticals, Inc. $23.98 07/17/2024 Food and Beverage Undisputed 01/23/2026 1114403313 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.